Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

NeuroSync Auditory-Cognitive Training for Listening in Noise in Hearing Aid Users

11 novembre 2026 aggiornato da: Busra Nur Eser, Medipol University

Improving and Evaluating Listening-in-Noise Performance in Hearing Aid Users

The goal of this clinical trial is to learn whether NeuroSync (Turkish: Nörosenkron), a 6-week, home-based, web-delivered auditory-cognitive training program, improves listening in noise in adults aged 18 to 65 years who use hearing aids in both ears for sensorineural hearing loss.

The main questions it aims to answer are:

  • Does NeuroSync training improve speech understanding in noise, measured with the Turkish Hearing in Noise Test (HINT)?
  • Does NeuroSync training reduce listening effort, measured with a dual-task test?

Researchers will compare NeuroSync training with an active control condition (watching "how-to" videos on the same web platform) to see whether the training leads to greater improvement.

Participants will:

  • Be assigned by chance to the NeuroSync training group or the video (active control) group
  • Complete 4 sessions per week for 6 weeks at home (24 sessions, each up to 30 minutes), while continuing their usual daily hearing aid use
  • Visit their hearing aid center before and after the 6-week period for hearing, listening-in-noise, and listening-effort tests and a questionnaire

Panoramica dello studio

Descrizione dettagliata

This is a multicenter, randomized, active-controlled, parallel-group trial with pre-test (T0) and post-test (T1) assessments. Adult bilateral hearing aid users are recruited from five hearing aid centers in collaboration with the Department of Audiology, Istanbul Medipol University.

After eligibility screening, written informed consent, and the baseline (T0) assessment, participants are randomized 1:1 to the NeuroSync training arm or the active control arm. Randomization is stratified by center, using computer-generated variable-size blocks. The allocation sequence is prepared and held by an independent person who is not involved in enrollment, training, or outcome assessment, and the allocation for each participant is disclosed only after T0 is complete. The trial is open label: participants, the team delivering the training, and the outcome assessor are aware of group assignment. In the HINT and the dual-task test, each response is scored by the assessor in view of the participant, and thresholds, reaction times, and medians are calculated by the test software.

NeuroSync is a Turkish-language, web-based program delivered at home (4 sessions per week for 6 weeks; 24 sessions; up to 30 minutes each). Sessions combine a music/rhythm warm-up, speech-in-noise listening tasks, working-memory and attention exercises, and a short narrative with comprehension questions. Content follows weekly daily-life themes, and difficulty increases gradually across the six weeks. Session completion and task performance are logged by the platform.

Participants in the active control arm continue routine hearing aid use and watch "how-to" videos on the same web platform, using individual log-in accounts so that viewing can be verified, on the same schedule and for the same session duration as the training arm. They receive no graded signal-to-noise ratio training, music-based or cognitive exercises, dual tasks, or performance feedback. Access to NeuroSync is offered to control participants after the study ends.

All assessments are performed at the centers with participants wearing their own bilateral hearing aids in their everyday program. The baseline (T0) assessment is completed within about 10 days before the intervention period, and the post-test (T1) assessment within about 10 days after the end of the 6-week period. The test order is SSQ12, HINT, dual-task listening-effort test, SMRT, and random gap detection test.

A minimum of 34 participants is required (repeated-measures within-between interaction, effect size f = 0.25, alpha = 0.05, power = 0.80); 40 participants (20 per arm) will be enrolled to allow for attrition. The primary outcome will be analyzed with a linear mixed model (group, time, and group-by-time interaction) following the intention-to-treat principle.

Tipo di studio

Interventistico

Iscrizione (Stimato)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Istanbul, Turchia (Türkiye)
        • Caddebostan Meta Ses İşitme Merkezi
      • Istanbul, Turchia (Türkiye)
        • Fenerbahçe Luna İşitme Merkezi
      • Istanbul, Turchia (Türkiye)
        • Nispetiye Luna İşitme Merkezi
      • Istanbul, Turchia (Türkiye)
        • NOVA İşitme Cihazları Satış ve Uygulama Merkezi
      • Istanbul, Turchia (Türkiye)
        • Şişli Meta Ses İşitme Merkezi

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Age 18 to 65 years
  • Bilateral, symmetric sensorineural hearing loss of mild, moderate, or moderately severe degree
  • Bilateral use of receiver-in-canal (RIC/RITE) or behind-the-ear (BTE) hearing aids
  • Bilateral hearing aid use for at least 3 months and at least 8 hours per day, verified by hearing aid data logging
  • Speech discrimination score of at least 52% in each ear
  • Standardized Mini-Mental State Examination score of at least 24
  • Native speaker of Turkish
  • Normal or corrected-to-normal visual acuity and normal color vision, sufficient to perform the color-based visual task
  • Basic ability to use the internet and a computer or tablet

Exclusion Criteria:

  • Unilateral or markedly asymmetric hearing loss
  • Conductive or mixed hearing loss, or active middle ear pathology
  • Cochlear implant use
  • Significant neurological disease or diagnosed cognitive impairment that could affect test performance
  • Uncontrolled psychiatric condition that could markedly affect participation in testing
  • Visual, motor, or communication impairment that prevents administration of the tests
  • Previous participation in a structured auditory and/or cognitive training program
  • Professional music training or current or past work as a professional musician

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: NeuroSync Auditory-Cognitive Training

Participants complete the NeuroSync (Nörosenkron) web-based auditory-cognitive training program at home: 4 sessions per week for 6 weeks (24 sessions, up to 30 minutes each), while continuing routine daily use of their own bilateral hearing aids (at least 8 hours per day).

Turkish-language, home-based, web-delivered auditory-cognitive training: 4 sessions per week for 6 weeks (24 sessions, up to 30 minutes each). Each session combines a music/rhythm warm-up, speech-in-noise listening and comprehension tasks, working-memory, attention and dual-task exercises, and a short narrative with comprehension questions. Content follows weekly daily-life themes. Difficulty increases progressively across the six weeks: the signal-to-noise ratio of the speech-in-noise tasks becomes less favorable and the musical and cognitive demands increase. Task-specific feedback is given. Session completion, accuracy, and reaction times are logged by the platform.

Altri nomi:
  • Nörosenkron
Comparatore attivo: Active Control: How-To Videos

Participants continue routine daily use of their own bilateral hearing aids (at least 8 hours per day) and watch "how-to" videos on the same web platform, with individual log-in accounts so that viewing is verified: 4 sessions per week for 6 weeks, matched in session duration to the training arm. No graded speech-in-noise training, music-based or cognitive exercises, dual tasks, or performance feedback are provided.

Participants watch "how-to" videos delivered through the same web platform as the training program, using individual user name and password log-in so that viewing can be verified: 4 sessions per week for 6 weeks, with the same session duration as the training arm. The condition is intended to balance study participation, exposure to auditory content, and researcher attention. It includes no graded signal-to-noise ratio training, music-based or cognitive exercises, dual tasks, or performance feedback. Participants continue routine daily hearing aid use.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Speech Reception Threshold in Noise on the Turkish Hearing in Noise Test (HINT)
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Adaptive signal-to-noise ratio (dB SNR) at which 50% of sentences are correctly recognized on the Turkish HINT. Tested in the sound field in a sound-treated booth with participants wearing their own bilateral hearing aids in their everyday program; speech and noise are presented from the same loudspeaker at 0 degrees azimuth, 1 m (S0N0), with noise fixed at 65 dB. Different sentence lists are used at T0 and T1. Change is calculated as T1 minus T0. Lower thresholds (a decrease) indicate better speech understanding in noise.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Dual-Task Cost 3 dB Below the HINT Threshold SNR
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = [(dual-task median RT - single-task median RT) / single-task median RT] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio 3 dB below (less favorable than) the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Cost at the HINT Threshold SNR
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = [(dual-task median RT - single-task median RT) / single-task median RT] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio equal to the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Cost 3 dB Above the HINT Threshold SNR
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = [(dual-task median RT - single-task median RT) / single-task median RT] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio 3 dB above (more favorable than) the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Speech, Spatial and Qualities of Hearing Scale 12-Item Version (SSQ12) Score
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Turkish SSQ12-A, a 12-item self-report questionnaire of everyday hearing ability, answered with reference to everyday listening with bilateral hearing aids. Each item is rated from 0 to 10; the scale score is the mean of the 12 items (range 0 to 10). Change is calculated as T1 minus T0. Higher scores (an increase) indicate better self-perceived hearing ability.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Speech Repetition Accuracy in the Dual-Task Listening-Effort Test
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Percentage of trials in which at least 3 of the 5 words of the Turkish Matrix Test sentence are repeated correctly during the dual-task test, reported separately for each of the three signal-to-noise ratio conditions (3 dB below, at, and 3 dB above the HINT threshold). Change is calculated as T1 minus T0 (percentage points). Higher values indicate better performance. Supportive outcome used to interpret the reaction-time measures.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Spectral-Temporally Modulated Ripple Test (SMRT) Threshold
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Spectro-temporal resolution threshold in ripples per octave (RPO) measured with SMRT software (three-interval forced-choice, adaptive 1-up/1-down procedure; threshold is the mean of the last six reversals), presented in the sound field at the participant's most comfortable level with bilateral hearing aids. Change is calculated as T1 minus T0. Higher values indicate better discrimination. Exploratory outcome.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Random Gap Detection Thresholds (Turkish RATET)
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Shortest inter-stimulus gap in milliseconds at which two tones are perceived as two sounds, measured separately at 500, 1000, 2000, and 4000 Hz with the Turkish random gap detection test (gaps of 0 to 40 ms), presented in the sound field at the most comfortable level with bilateral hearing aids. If two sounds are not perceived at 40 ms, the result is recorded as greater than 40 ms (right-censored). Lower thresholds indicate better temporal resolution. Exploratory outcome.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Participant Satisfaction With the NeuroSync Program
Lasso di tempo: Post-test (T1, at the end of the 6-week intervention period)

Five-question satisfaction questionnaire developed by the investigators, administered only to the experimental arm. Responses are reported descriptively as the distribution of answers to each question.

Post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time 3 dB Below the HINT Threshold SNR
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio 3 dB below (less favorable than) the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time at the HINT Threshold SNR
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio equal to the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time 3 dB Above the HINT Threshold SNR
Lasso di tempo: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio 3 dB above (more favorable than) the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Direttore dello studio: M. Bülent Şerbetçioğlu, MD, PhD, Istanbul Medipol University, Department of Audiology

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

16 novembre 2026

Completamento primario (Stimato)

1 febbraio 2027

Completamento dello studio (Stimato)

1 febbraio 2027

Date di iscrizione allo studio

Primo inviato

11 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

11 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be deposited in a repository; requests may be considered by the investigators after publication. Any data provided would be coded and would not include names or other direct identifiers.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi